WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.04 Cr | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-7.04 Cr |
| Mar2024 | ₹-5.50 Cr |
| Mar2023 | ₹-5.50 Cr |
| Mar2022 | ₹-5.63 Cr |
| Mar2021 | ₹-5.63 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.04 Cr | Negative | |
| Mar2024 | ₹-5.50 Cr | Negative | |
| Mar2023 | ₹-5.50 Cr | Negative | |
| Mar2022 | ₹-5.63 Cr | Negative | |
| Mar2021 | ₹-5.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹805.3 Cr | 1.2% | -2.1% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 1.2% |
-2.1% |
-14.3% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses